2,2,3-trifluoro-3-(trifluoromethyl)oxirane

We are 2,2,3-trifluoro-3-(trifluoromethyl)oxirane CAS:428-59-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2,2,3-trifluoro-3-(trifluoromethyl)oxirane
CAS.NO:428-59-1
Synonyms:2,2,3-trifluoro-3-(trifluoromethyl)oxirane
perfluoropropylene oxide
hexafluorocyclopropylene oxide
Perfluoro-1,2-propenoxide
hexafluoro-1,2-epoxypropane
Hfpo
Molecular Formula:C3F6O
Molecular Weight:166.02200
 
Physical and Chemical Properties:
Melting point:-129ºC
Boiling point:−42ºC
 
Specification:
Appearance:Colorless transparent gas
Assay:≥99.0%
Hexafluoropropylene:≤0.8%
Other impurities:≤0.2%
 
Packing:400L/Cylinder, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate

2,2,3-trifluoro-3-(trifluoromethyl)oxirane


Related News: Biogen last month revived its plans to seek U.S. approval for its aducanumab treatment after announcing in March that it would terminate two large clinical trials for the drug. But some analysts believed FDA approval is highly unlikely.o-Toluic acid CAS:118-90-1 The quality of the drug substance determines the quality of the preparation, so its quality standards are very strict. Countries around the world have formulated strict national pharmacopoeia standards and quality control methods for their widely used drug substances.5-fluoro-3-nitropiridin-2-amina CAS:212268-12-7 INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.2-cloro-3-isotiocianatoprop-1-eno CAS:14214-31-4 This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.The use of contrast agents is different from other drugs, and it needs to be used with corresponding equipment. In recent years, China is in the growth period of imaging equipment.

Related Products
Product Name
2-Cyanobenzyl chloride View Details
N-Boc-L-phenylalaninal View Details
N-Carbobenzoxy-beta-alanine View Details
2-((1-Benzylpiperidin-4-yl)methylene)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one manufacturer 2-Fluoro-4-methoxybenzonitrile manufacturer 2,3-Difluoroaniline manufacturer 3-((S)-1-tert-butoxycarbonyl-4-oxo-2-pyrrolidinylcarbonyl)-1,3-thiazolidine manufacturer (2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)methanol manufacturer